News & Updates
Filter by Specialty:
Molnupiravir speeds up recovery, reduces viral load of vaccinated COVID-19 patients
In vaccinated adults with COVID-19 who are at higher risk of adverse outcomes, treatment with molnupiravir in addition to usual care falls short of reducing the rates of hospitalizations and deaths, as shown by the results of the PANORAMIC study.
Molnupiravir speeds up recovery, reduces viral load of vaccinated COVID-19 patients
21 Apr 2023
Long COVID profoundly affects patients' QoL
In a functional assessment of post-COVID long-term sequelae, individuals suffering from long COVID (having at least one symptom of post-COVID-19 syndrome) had poorer quality of life (QoL) than those unaffected by the syndrome.
Long COVID profoundly affects patients' QoL
21 Apr 2023
Can an antibody-drug conjugate alter the treatment landscape of difficult-to-treat ovarian cancer?
Mirvetuximab soravtansine (MIRV), an antibody drug conjugate (ADC), showed antitumour activity in women with platinum-resistant ovarian cancer* (PROC) with high folate receptor alpha (FRα) expression, findings from the phase III SORAYA study have shown.
Can an antibody-drug conjugate alter the treatment landscape of difficult-to-treat ovarian cancer?
20 Apr 2023
Certain reproductive factors tied to premature menopause in Asians
Women with histories of infertility, recurrent miscarriages, and stillbirths are more likely to experience premature or early menopause, with stronger associations observed for Asian women, as reported in a study.